Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils

Journal of Alzheimer's Disease

Volumn 37, Issue 1, 2013, Pages 19-28

  Zhang, Yingjiu ^b   Cui, Lili ^a,b   Zhang, Yuan ^b   Cao, Hao ^b   Wang, Yan ^a   Teng, Teng ^b   Ma, Guoda ^a   Li, You ^a   Li, Keshen ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; amyloid ; ferulic acid; oligomer

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN 42 MONOMER; AMYLOID BETA PROTEIN 42 OLIGOMER; AMYLOID BETA PROTEIN[1-42]; FERULIC ACID; MONOMER; OLIGOMER; THIOFLAVINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; CYTOTOXICITY; DEPOLYMERIZATION; FLUORESCENCE ANALYSIS; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DOCKING; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; AMYLOID BETA-PEPTIDES; BINDING SITES; CELL LINE, TUMOR; CELL SURVIVAL; COUMARIC ACIDS; FREE RADICAL SCAVENGERS; HUMANS; PEPTIDE FRAGMENTS;

EID: 84883161880     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130164     Document Type: Article

References (41)

1. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222.
2. Selkoe DJ (2006) The ups and downs of Abeta. Nat Med 12, 758-759.
3. Benseny-Cases N, Ćocera M, Cladera J (2007) Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation. Biochem Biophys Res Commun 361, 916-921. (Pubitemid 47263455)
4. Thapa A, Woo ER, Chi EY, Sharoar MG, Jin HG, Shin SY, Park IS (2011) Biflavonoids are superior to monoflavonoids in inhibiting Amyloid-toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures. Biochemistry 50, 2445-2455.
5. Ferreira ST, Vieira MN, De Felice FG (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59, 332-345. (Pubitemid 46763764)
6. Cui L, Huang X, Wang J, Zhang Y (2010) Specific and efficient anti-Ar42 antibodies induced by sixteen tandem repeats of Ar9. J Neuroimmunol 227, 18-25.
7. Taylor M, Moore S, Mourtas S, Niarakis A, Re F, Zona C, La Ferla B, Nicotra F, Masserini M, Antimisiaris SG, Gregori M, Allsop D (2011) Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's A, peptide. Nanomedicine 7, 541-550.
8. Durairajan SS, Yuan Q, Xie L, Chan WS, Kum WF, Koo I, Liu C, Song Y, Huang JD, Klein WL, LiM(2008) Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty. Neurochem Int 52, 741-750.
9. Lu P, Mamiya T, Lu LL, Mouri A, Zou L, Nagai T, Hiramatsu M, Ikejima T, Nabeshima T (2009) Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol 157, 1270-1277.
10. Gervais F, Paquette J, Morissette C (2007) Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiol Aging 28, 537-547. (Pubitemid 46282205)
11. Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer's-amyloid fibrils in vitro. J Neurosci Res 75, 742-750. (Pubitemid 38296087)
12. Yang F, LimGP,BegumAN, Ubeda OJ, SimmonsMR,Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautzchy SA, ColeGM(2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280, 5892-5901. (Pubitemid 40280072)
13. Aisen PS, Gauthier S, Ferris SH, Saumier D, Haine D, Garceau D, Duong A, Suhy J, Oh J, Lau WC, Sampalis J (2011) Tramiprosate in mild-to-moderate Alzheimer's disease-a randomized, double-blind, placebo-controlled, multicentre study (the Alphase Study). Arch Med Sci 7, 102-111.
14. Itagaki S, Kurokawa T, Nakata C, Saito Y, Oikawa S, Kobayashi M, Hirano T, Iseki K (2009) In vitro and in vivo antioxidant properties of ferulic acid: a comparative study with other natural oxidation inhibitors. Food Chem 114, 446-471.
15. Basakaran N, Manoharan S, Balakrishnan S, Pugalendhi P (2010) Chemo preventive potential of ferulic acid in 7,12-dimethylbenz [a] anthracene-inducedmammarycarcinogenesis in Sprague-Dawley rats. Euro J Pharmacol 637, 22-29.
16. Srinivasan M, Rukkumani R, Sudheer ARR, Menon VP (2005) Ferulic acid, a natural protector against carbon tetrachlorideinduced toxicity. Fundam Clin Pharmacol 19, 491-496. (Pubitemid 41002420)
17. Murakami A, Nakamura YKK, Takahashi D, Matsumoto K, Haihara K (2002) FA15, a hydrophobic derivative of ferulic acid, suppresses inflammatory responses and skin tumor promotion: comparison with ferulic acid. Cancer Lett 180, 121-129. (Pubitemid 34327364)
18. Ono K, Hirohata M, Yamada M (2005) Ferulic acid destabilizes preformed-amyloid fibrils in vitro. Biochem Biophys Res Commun 336, 444-449. (Pubitemid 41267250)
19. Yan JJ, Jung JS, Kim TK, Hasan A, Hong CW, Nam JS, Song DK (2012) Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease. Biol Pharm Bull 36, 140-143.
20. Cho JY, Kim HS, Kim DH, Yan JJ, Suh HW, Song DK (2005) Inhibitory effects of long term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide(1-42) in mice. Prog Neuropsychopharmacol Biol Psychiatry 29, 901-907.
21. Mastrangelo IA, Ahmed M, Sato T (2006) High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol 358, 106-119.
22. Fezoui Y, Teplow DB (2002) Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. J Biol Chem 277, 36948-36954.
23. De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV (2012) Alzheimer's disease. Subcell Biochem 65, 329-352.
24. Feng Y, Yang SG, Du XT, Zhang X, Sun XX, Zhao M, Sun GY, Liu RT (2009) Ellagic acid promotes Ar42 fibrillization and inhibits Ar42-induced neurotoxicity. Biochem Biophys Res Commun 390, 1250-1254.
25. Necula M, Breydo L, Milton S, Kayed R, van der Veer WE, Tone P, Glabe CG (2007) Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry 46, 8850-8860. (Pubitemid 47208418)
26. Kanski J, Aksenova M, Stoyanova A, Butterfield DA (2002) Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem 13, 273-281. (Pubitemid 34556688)
27. Yan JJ, Cho JY, Kim HS, Kim KL, Jung JS, Huh SO, SuhHW, Kim YH, Song DK (2001) Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133, 89-96.
28. Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA (2005) Ferulic acid ethyl ester protects neurons against amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 92, 749-758. (Pubitemid 40229546)
29. Roychaudhuri R,Yang M, Deshpande A, Cole GM, Frautschy S, Lomakin A, Benedek GB, Teplow DB (2013) C-Terminal Turn Stability Determines Assembly Differences between Af;40 and Ar42. J Mol Biol 425, 292-308.
30. Walsh DM, Selkoe DJ (2007) A,oligomers-a decade of discovery. J Neurochem 101, 1172-1184.
31. Morimoto A, Irie K, Murakami K, Masuda Y, Ohigashi H, Nagao M, Fukuda H, Shimizu T, Shirasawa T (2004) Analysis of the secondary structure of-amyloid (Ar42) fibrils by systematic praline replacement. J Biol Chem 279, 52781-52788. (Pubitemid 39656654)
32. Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO (2010) Structural conversion of neurotoxic Amyloid-1-42 oligomers to fibrils. Nat Struct Mol Biol 7, 561-567.
33. Tycko R (2006) Molecular structure of amyloid fibrils: insights from solid-state NMR. Q Rev Biophys 39, 1-55. (Pubitemid 44566373)
34. Paravastu AK, Leapman RD, Yau WM, Tycko R (2008) Molecular structural basis for polymorphism in Alzheimer's-amyloid fibrils. Proc Natl Acad Sci USA 105, 18349-18354.
35. Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, Han F, Mao X, Ikeda T, Takasaki J, Nishijo H, Takashima A, Teplow DB, Zagorski MG, Yamada M (2012) Phenolic compounds prevent amyloid-protein oligomerization and synaptic dysfunction by site-specific binding. J Biol Chem 287, 14631-14643.
36. Crisostomo AG, Moreno RB, Navaratnam S, Wilkinson JA, Bisby RH (2007) Generation of superoxide and singlet oxygen from alpha-tocopherolquinone and analogues. Free Radic Res 41, 730-737. (Pubitemid 46845594)
37. Convertino M, Pellarin R, Catto M, Carotti A, Caflisch A (2009) 9,10-Anthraquinone hinders beta-aggregation: how does a small molecule interfere with Abeta-peptide amyloid fibrillation? Protein Sci 18, 792-800.
38. HillsRDJr, BrooksCL3rd (2007) Hydrophobic cooperativity as a mechanism for amyloid nucleation. J Mol Biol 368, 894-901. (Pubitemid 46527619)
39. Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug 67, 27-37. (Pubitemid 43881385)
40. Yang SG,Wang WY, Ling TJ, Feng Y, Du XT, Zhang X, Sun XX, Zhao M, Xue D,YangY, LiuRT(2010) Alpha-tocopherol quinone inhibits beta-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines. Neurochem Int 57, 914-922.
41. Findeis MA (2000) Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization. Biochim Biophys Acta 1502, 76-84. (Pubitemid 30433857)